论文部分内容阅读
奥美拉唑（OmeprazoleOME）是一种新型胃酸分泌抑制剂。1982年应用于临床。它能选择性、非竞争性抑制壁细胞膜中质子泵H＋K＋ATP酶，作用胃酸分泌终末环节，有较强的抑制胃酸分泌作用。大宗资料证明，它对消化性溃疡（PU）等有较好疗效，副作用少，国内一组报告占5．5％[1]，De
OmeprazoleOME is a new inhibitor of gastric acid secretion. Applied to clinical in 1982. It can selective, non-competitive inhibition of parietal cell membrane proton pump H + K ATPase, the role of gastric acid secretion in the terminal part of a strong inhibition of gastric acid secretion. A large body of evidence that it has a good effect on peptic ulcer (PU), with fewer side effects, a group of domestic reports accounted for 5.5% [1], De